Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Caesarean Sections
NCT02492087Phase 3
Key facts
- Status
- Unknown
- Start
- Aug 2015
- Primary completion
- Dec 2016
- Countries
- 1
- Modality
- Small Molecules
- Drugs
- tranexamic acid
- Conditions
- postpartum hemorrhage (PPH)
01
Overview
Phase 3, randomised trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms). Primary endpoint: Total intra-operative blood loss. Status: unknown.
02
Design
2 arms- Study design
- Randomized
Tranexamic acid Group
Topical Tranexamic acid 2g
Control Group
Normal saline 0.9%
03
Who it enrols
Parturients planned for caesarean section under regional anaesthesia with moderate to high risk of bleeding (e.g., placenta previa, preeclampsia, anemia, obesity).
04
Endpoints
Primary
Total intra-operative blood loss
Secondary
Transfusion requirements
Haematocrit trends
Beyond the preview
Go deeper on NCT02492087.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492087.